🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a multicenter, Phase I, open-label, randomized, 2-sequence, 2...
Status
Completed
Location
Research Site
Start Date
2021-02-25
Trial ID
NCT04768985
Treatments Being Tested
Phase 2, two cohort trial evaluating the addition of ublituximab and umbral...
Status
Terminated
Location
TG Therapeutics Investigational Trial Site
Start Date
2019-08-05
Trial ID
NCT04016805
Treatments Being Tested
This study will evaluate the effect of fluconazole and isavuconazole on the...
Status
Completed
Location
Celerion
Start Date
2020-01-03
Trial ID
NCT05140096
Treatments Being Tested
This study is to evaluate the effects of single therapeutic and supratherap...
Status
Completed
Location
Celerion
Start Date
2016-04-01
Trial ID
NCT04867980
Treatments Being Tested
This Phase 1 study is being conducted to support the clinical development o...
Status
Completed
Location
Research Site
Start Date
2020-10-12
Trial ID
NCT04564040
This study will be a 2-part, open-label, single-center relative bioavailabi...
Status
Completed
Location
Research Site
Start Date
2020-06-24
Trial ID
NCT04488016
The main purpose of the study is to evaluate if adding venetoclax to partic...
Status
Active Not Recruiting
Location
Highlands Oncology Group
Start Date
2024-08-09
Trial ID
NCT06524375
Treatments Being Tested
This research study is studying a combination of drugs as a possible treatm...
Status
Recruiting
Location
Massachusetts General Hospital Cancer Center
Start Date
2020-10-19
Trial ID
NCT04560322
Treatments Being Tested
This study aims to evaluate the safety, tolerability, pharmacodynamic, and ...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital ( Site 0140)
Start Date
2017-06-26
Trial ID
NCT03162536
Treatments Being Tested